PEDIATRICS Vol. 111 No. 1 January 2003, pp. 167-170
Bleeding Tendency in Children With Alagille Syndrome




* Service dHépatologie pédiatrique
Laboratoire dHématologie, Hôpital de Bicêtre, Le Kremlin Bicêtre Cedex, France
Unité INSERM 347, Le Kremlin Bicêtre Cedex, France
--> Objective. Spontaneous intracranial bleeding is now a widely recognized complication and cause of mortality in patients with Alagille syndrome. The pathogenesis of intracranial bleeding in these patients remains unclear. The aim of the study was to look for other sites of bleeding in these patients that could suggest a factor of multiorgan morbidity.
Methods. The records of 174 patients with Alagille syndrome were reviewed, and 38 (22%) patients without liver failure who experienced hemorrhage that led to a drop in hemoglobin level of at least 3 g/dL or to blood transfusion were identified.
Results. In 38 patients, 49 bleeding episodes occurred at a median age of 3.75 years (range: 1 month27 years). Seventeen patients had 23 episodes of spontaneous bleeding; 21 patients bled during surgery or other medical procedures, and 5 among these 21 patients also had a spontaneous bleeding episode. Nine patients bled at least twice. Median platelets count and prothrombin time were normal. Severe cholestasis existed in 33 patients. One patient has a deletion of the 20p12 region, and 13 of 17 patients studied have a JAGGED1 mutation. Blood transfusion was necessary in 23 patients. Eight patients died secondary to bleeding (4 after surgery, 2 after gastrointestinal bleeding, 1 after needle liver biopsy, and 1 after intracranial bleeding).
Conclusion. These results suggest that patients with Alagille syndrome are at special risk for bleeding; this should be taken into account before deciding on an invasive procedure. The mechanism of the bleeding is still unclear; the role of hypercholesterolemia cannot be excluded, but it may be speculated that JAGGED1 signaling abnormalities may impair the hemostatic function.
Key Words: Alagille syndrome hemorrhage JAGGED1 hemostasism
Abbreviations: AGS Alagille syndrome
Received for publication Mar 26, 2002; Accepted Jul 26, 2002.
This article has been cited by other articles:
![]() |
M. E. Pierpont, C. T. Basson, D. W. Benson Jr, B. D. Gelb, T. M. Giglia, E. Goldmuntz, G. McGee, C. A. Sable, D. Srivastava, and C. L. Webb Genetic Basis for Congenital Heart Defects: Current Knowledge: A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics Circulation, June 12, 2007; 115(23): 3015 - 3038. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N.K. Odim, J. Wu, H. Laks, A. Banerji, and S. Drant Cardiac Surgery in Children With End-Stage Liver Disease Awaiting Liver Transplantation Ann. Thorac. Surg., February 1, 2006; 81(2): 697 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hadchouel, B. M. Kamath, N. B. Spinner, D. A. Piccoli, I. D. Krantz, K. M. Emerick, A. E. Chudley, and C. Booth Vascular Anomalies in Alagille Syndrome * Response Circulation, September 28, 2004; 110(13): e327 - e327. [Full Text] [PDF] |
||||






